Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile-Associated Disease - Al-Nassir, Wafa N.; Sethi, Ajay K.; Li, Yuejin; Pultz, Michael J.; Riggs, Michelle M.; Donskey, Curtis J. (Antimicrobial Agents and Chemotherapy, 2008)
Keywords: Administration, Oral; Aged; Aged, 80 and over; Antibiotics. Antiinfectious agents. Antiparasitic agents; Biological and medical sciences; Clinical Therapeutics; Clostridium difficile - drug effects; Cross Infection; Cross Infection - drug therapy; Cross Infection - microbiology; Enterococcus; Enterococcus - drug effects; Enterococcus - growth & development; Enterocolitis, Pseudomembranous; Enterocolitis, Pseudomembranous - drug therapy; Enterocolitis, Pseudomembranous - microbiology; Female; Humans; Male; Medical sciences; Metronidazole; Metronidazole - administration & dosage; Metronidazole - adverse effects; Middle Aged; Pharmacology. Drug treatments; Prospective Studies; Vancomycin; Vancomycin - administration & dosage; Vancomycin - adverse effects; Vancomycin Resistance; Nitro compound; Imidazole derivatives; Lactic acid bacteria; Peptides; Clostridiales; Vancomycin; Antiprotozoal agent; Antifungal agent; Glycopeptide; Bacteria; Micrococcales; Intestinal disease; Enterococcus; Clostridium difficile; Oral administration; Diarrhea; Streptococcaceae; Antibiotic; Treatment; Polypeptide; Clostridiaceae; Digestive diseases; Parasiticide; Metronidazole; Antibacterial agent